Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Cancer Research
|
December 1, 1988
Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats
D S Marsman, R C Cattley, J G Conway, et al.
Carcinogenesis
|
January 1, 1995
TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion
R T Miller, R C Cattley, D S Marsman, et al.
Cancer Letters
|
April 29, 1994
Retrospective assessment of liver cell proliferation via PCNA: a comparison with tritiated thymidine
D R Dietrich, R Candrian, D S Marsman, et al.
Carcinogenesis
|
March 1, 1989
Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643
J G Conway, K E Tomaszewski, M J Olson, et al.
Toxicology and Applied Pharmacology
|
March 1, 1993
The nongenotoxic hepatocarcinogen Wy-14,643 is an uncoupler of oxidative phosphorylation in vivo
B J Keller, B U Bradford, D S Marsman, et al.
European Journal of Nutrition
|
June 30, 2019
Nutrition interventions for healthy ageing across the lifespan: a conference report
A Kalache, A I de Hoogh, S E Howlett, et al.
Molecular Pharmacology
|
November 1, 1996
Rat 17 beta-hydroxysteroid dehydrogenase type IV is a novel peroxisome proliferator-inducible gene
J C Corton, C Bocos, E S Moreno, et al.
Regulatory Toxicology and Pharmacology : RTP
|
June 18, 1998
Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?
R C Cattley, J DeLuca, C Elcombe, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Cancer Research
|
December 1, 1988
Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats
D S Marsman, R C Cattley, J G Conway, et al.
Carcinogenesis
|
January 1, 1995
TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion
R T Miller, R C Cattley, D S Marsman, et al.
Cancer Letters
|
April 29, 1994
Retrospective assessment of liver cell proliferation via PCNA: a comparison with tritiated thymidine
D R Dietrich, R Candrian, D S Marsman, et al.
Carcinogenesis
|
March 1, 1989
Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643
J G Conway, K E Tomaszewski, M J Olson, et al.
Toxicology and Applied Pharmacology
|
March 1, 1993
The nongenotoxic hepatocarcinogen Wy-14,643 is an uncoupler of oxidative phosphorylation in vivo
B J Keller, B U Bradford, D S Marsman, et al.
European Journal of Nutrition
|
June 30, 2019
Nutrition interventions for healthy ageing across the lifespan: a conference report
A Kalache, A I de Hoogh, S E Howlett, et al.
Molecular Pharmacology
|
November 1, 1996
Rat 17 beta-hydroxysteroid dehydrogenase type IV is a novel peroxisome proliferator-inducible gene
J C Corton, C Bocos, E S Moreno, et al.
Regulatory Toxicology and Pharmacology : RTP
|
June 18, 1998
Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?
R C Cattley, J DeLuca, C Elcombe, et al.
Page
of 2